Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Chubb
Farmers Insurance
Covington
Dow
Daiichi Sankyo
Boehringer Ingelheim
US Army
US Department of Justice
Express Scripts

Generated: January 21, 2018

DrugPatentWatch Database Preview

HUMALOG Drug Profile

« Back to Dashboard

When do Humalog patents expire, and when can generic versions of Humalog launch?

Humalog is a drug marketed by Lilly and Eli Lilly And Co and is included in four NDAs. There are three patents protecting this drug.

The generic ingredient in HUMALOG is insulin lispro protamine recombinant; insulin lispro recombinant. There are thirty-nine drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the insulin lispro protamine recombinant; insulin lispro recombinant profile page.
Summary for HUMALOG
US Patents:0
Applicants:2
NDAs:4
Suppliers / Packagers: 4
Clinical Trials: 111
Drug Prices:see details
DailyMed Link:HUMALOG at DailyMed
Drug patent expirations by year for HUMALOG
Pharmacology for HUMALOG
Ingredient-typeInsulin
Drug ClassInsulin Analog

US Patents and Regulatory Information for HUMALOG

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly HUMALOG insulin lispro recombinant INJECTABLE;INJECTION 020563-001 Jun 14, 1996 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Eli Lilly And Co HUMALOG KWIKPEN insulin lispro recombinant SOLUTION;SUBCUTANEOUS 205747-001 May 26, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Lilly HUMALOG MIX 75/25 KWIKPEN insulin lispro protamine recombinant; insulin lispro recombinant INJECTABLE;INJECTION 021017-002 Sep 6, 2007 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Lilly HUMALOG MIX 50/50 insulin lispro protamine recombinant; insulin lispro recombinant INJECTABLE;INJECTION 021018-001 Dec 22, 1999 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly HUMALOG PEN insulin lispro recombinant INJECTABLE;INJECTION 020563-002 Aug 6, 1998 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly HUMALOG KWIKPEN insulin lispro recombinant INJECTABLE;INJECTION 020563-003 Sep 6, 2007 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Eli Lilly And Co HUMALOG KWIKPEN insulin lispro recombinant SOLUTION;SUBCUTANEOUS 205747-001 May 26, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Eli Lilly And Co HUMALOG KWIKPEN insulin lispro recombinant SOLUTION;SUBCUTANEOUS 205747-001 May 26, 2015 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Lilly HUMALOG MIX 50/50 PEN insulin lispro protamine recombinant; insulin lispro recombinant INJECTABLE;INJECTION 021018-003 Dec 22, 1999 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly HUMALOG MIX 75/25 PEN insulin lispro protamine recombinant; insulin lispro recombinant INJECTABLE;INJECTION 021017-003 Dec 22, 1999 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for HUMALOG

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly HUMALOG insulin lispro recombinant INJECTABLE;INJECTION 020563-001 Jun 14, 1996 ➤ Subscribe ➤ Subscribe
Lilly HUMALOG insulin lispro recombinant INJECTABLE;INJECTION 020563-001 Jun 14, 1996 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Chubb
Queensland Health
Cipla
Fuji
US Department of Justice
McKesson
US Army
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot